Loading organizations...
Baker & Eastlack Ventures operates as a specialized venture capital firm, strategically deploying capital into early-stage companies within the medical device and diagnostics sector. The firm leverages its profound industry acumen to pinpoint and support nascent enterprises developing innovative healthcare solutions, offering both financial backing and strategic guidance to propel their growth.
The firm was co-founded in 2016 by Kenneth Baker and Robert Eastlack, arising from a shared conviction that targeted expertise was essential for navigating the complex landscape of healthcare innovation. Both founders contribute a rich background spanning patient care, healthcare operations, and investment strategies, providing a robust foundation for identifying and nurturing promising medical technology ventures.
Baker & Eastlack Ventures primarily serves emerging growth companies in the medical device and diagnostics space that are actively seeking initial funding and strategic partnerships. The firm is driven by a vision to cultivate advancements that enhance patient care and significantly contribute to the evolution of healthcare delivery through judicious investment in transformative technologies.
Baker & Eastlack Ventures has 1 tracked investment across 1 company. The latest tracked deal is $3.1M Seed in UroDev Medical in October 2017.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 19, 2017 | UroDev Medical | $3.1M Seed | Baker & Eastlack Ventures | Ivernet, OC Service Academy Angels, Particular Ventures, Santa Barbara Angel Alliance, Storm Industries, SV Tech Ventures, Western Technology Investment, Y Combinator |